Shen Fang, Wen Liang, Yang Xiaofeng, Liu Weiguo
Department of Neurosurgery, First Affiliated Hospital, College of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou City, 310003 Zhejiang, People's Republic of China.
Neurosurg Rev. 2007 Oct;30(4):291-8; discussion 298. doi: 10.1007/s10143-007-0094-4. Epub 2007 Aug 9.
Advances in molecular biology have allowed the possibility of using gene therapy in the treatment of traumatic brain injury. The major tactics involve picking out the appropriate gene target and, by controlling its specific regional expression, inhibiting neuronal cell deaths and/or promoting neuronal regeneration. This review addresses the preliminary usage of gene therapy in in vitro experiments and in animal models to treat traumatic brain injury. The gene targets with therapeutic potentials, the vectors that can be employed to deliver the candidate genes, as well as different approaches for gene therapy are discussed in detail in this review. Despite the existence of several major obstacles to making it practical and effective, gene therapy could provide a new strategy for treatment of the traumatically injured brain.
分子生物学的进展使得在创伤性脑损伤治疗中使用基因治疗成为可能。主要策略包括挑选合适的基因靶点,并通过控制其特定区域的表达来抑制神经元细胞死亡和/或促进神经元再生。本文综述了基因治疗在体外实验和动物模型中治疗创伤性脑损伤的初步应用。文中详细讨论了具有治疗潜力的基因靶点、可用于递送候选基因的载体以及基因治疗的不同方法。尽管在使其切实可行和有效方面存在几个主要障碍,但基因治疗可为创伤性脑损伤的治疗提供一种新策略。